Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PLA
(phospholipases A) are important mediators of cell signaling, generating bioactive fatty acids and LPLs (lysophospholipids).
PLA
products having different head groups can initiate vastly different types of signaling. Fluorogenic analogues of the PLs (phospholipids) PA (phosphatidic acid), PC (phosphatidylcholine), PE (phosphatidylethanolamine), and PG (phosphatidylglycerol) were synthesized as
PLA
substrates for rapidly determining in real time the influence of head group modifications on cell signaling both in vitro and in cells. Enzyme-assisted remodeling of the sn-2 position of the diacylglyceryl moiety with cobra venom
PLA
2 and transphosphatidylation with a particular PLD (phospholipase D) were central steps in the preparation of these enzymatic probes. The resulting fluorogenic Dabcyl- and BODIPY-containing PL analogues,
DBPA
, DBPC, DBPE, and DBPG, were used in mixed micelle assays to determine
PLA
2 kinetics. Next, the assays were used to determine the X i (50) value of a common
PLA
2 inhibitor. Finally, the head group selectivities of a series of commercially available
PLA
2 enzymes were readily established using the DBPLs (Dabcyl-BODIPY PLs) as substrates.
...
PMID:Fluorogenic phospholipids as head group-selective reporters of phospholipase A activity. 1716 43